Advice
following an abbreviated submission:
fosfomycin trometamol (Monuril®) is accepted for use within NHS Scotland.
Indication under review:
• Treatment of acute lower uncomplicated urinary tract infections, caused by pathogens sensitive to fosfomycin in adult and adolescent females.
• Prophylaxis in diagnostic and surgical transurethral procedures.
Consideration should be given to national guidance on the appropriate use of antibacterial agents.
Unlicensed preparations of oral fosfomycin have been used in the NHS in Scotland. The availability of fosfomycin trometamol (Monuril®) provides a licensed preparation. Estimated patient numbers are expected to be small.
Download detailed advice112KB (PDF)
Medicine details
- Medicine name:
- fosfomycin trometamol granules for oral solution (equivalent to 3g fosfomycin) (Monuril)
- SMC ID:
- 1163/16
- Indication:
- Treatment of acute lower uncomplicated urinary tract infections, caused by pathogens sensitive to fosfomycin in adult and adolescent females. Prophylaxis in diagnostic and surgical transurethral procedures.
- Pharmaceutical company
- Profile Pharma Ltd
- BNF chapter
- Infections
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 12 September 2016